X0508 4 2025-02-09 0 0002022416 Silexion Therapeutics Corp SLXN 0002048879 Peled Amnon C/O SILEXION THERAPEUTICS CORP 12 ABBA HILLEL ROAD RAMAT GAN L3 5250606 ISRAEL 1 0 0 0 0 Ordinary Shares 2025-02-09 4 A 0 661 0 A 661 D Stock Option (right to buy Ordinary Shares) 18.90 2025-02-09 4 A 0 780 0 A 2026-02-09 2035-02-09 Ordinary Shares 780 780 D Represents ordinary shares underlying RSUs granted to the Reporting Person by the Issuer, as consideration for the Reporting Person's service on the Issuer's board of directors. The shares subject to this award vest in full on the first anniversary of the grant date (i.e., on February 9, 2026), subject to the Reporting Person's continued service through such date. The number of ordinary shares reported in this row has been adjusted retroactively to reflect a 1-for-15 reverse share split effected by the Issuer on July 29, 2025. The number of options to purchase ordinary shares, and underlying ordinary shares, reported in this row have been adjusted downwards, and the exercise price of those options has been adjusted proportionately upwards, to reflect the 1-for-15 reverse share split effected by the Issuer on July 29, 2025. All of the stock options reported in this row vest (and become exercisable) on the first anniversary of the grant date (i.e., on February 9, 2026), subject to the Reporting Person's continued service through such date. /s/ Mirit Horenshtein Hadar, Attorney-in-fact 2025-12-31